Antibodies against COVID (enrolling by invitation)

Overview

About this study

The study is being done to identify how many Healthcare workers develop antibodies against the SARS-CoV 2 virus over a 6 month period

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

  • Is a nurse, physician, nurse practitioner, physician assistant, respiratory therapist, patient care assistant who has worked at least 10 shifts in the last 45 days in direct patient care
  • Is a Mayo Clinic employee in any role who has <7 days on campus in a patient care role OR has had no patient contact in the last 45 days prior to enrollment

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Priya Sampathkumar, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions